https://www.selleckchem.com/products/ml141.html
77; Competence subscale ICC=.51), with therapists exhibiting good-to-excellent levels of fidelity across all trials. Importantly, linear mixed modeling indicated that higher levels of overall fidelity were associated with greater reductions in opioid misuse across two Stage 2 RCTs ( =7.38, =.009), indicating that the MORE-FM is a valid measure of treatment fidelity that can predict clinical outcomes. Findings from this study yielded insights for future iterations of the MORE-FM. In sum, the MORE-FM is a valuable tool for assessing and enh
Like
Comment
Share
